Clinical application of MOLLI T1* for extracellular volume calculation in healthy volunteers and aortic stenosis by Anish N Bhuva et al.
POSTER PRESENTATION Open Access
Clinical application of MOLLI T1* for extracellular
volume calculation in healthy volunteers and
aortic stenosis
Anish N Bhuva*, Thomas A Treibel, Arthur Nasis, Stefania Rosmini, Amna Abdel-Gadir, Heerajnarain Bulluck,
Charlotte Manisty, James Moon
From 18th Annual SCMR Scientific Sessions
Nice, France. 4-7 February 2015
Background
The calculation of the extracellular volume fraction
(ECV) requires accurate quantification of myocardial
and blood pool T1. Some Modified look locker inversion
recovery (MOLLI) sequences provide a T1 and T1* out-
put. T1* does not use a look locker correction, and so it
is theoretically a more accurate estimation of true T1
blood T1 because fresh spins are flowing into the ima-
ging plane. It is therefore recommended to use T1* for
the quantification of the pre- and post-contrast blood
pool. The aim of this study was to investigate the effect
on ECV of using T1* (ECVT1*) rather than T1 (ECVT1)
and assess accuracy, precision and bias.
Methods
57 patients with aortic stenosis (AS) (mean age= 71±10
years, 33 female) and 25 healthy volunteers (HV) (mean
age= 40±11 years, 19 female) were recruited. 4 chamber
and mid ventricular short axis (SA) T1 maps were
acquired pre-contrast and 15 minute post-contrast using
5s(3s)3s and 4s(1s)3s(1s)2s sequences respectively.
Regions of interest (ROI) were drawn carefully to avoid
blood-myocardium border and copied across series with
correction only for patient movement. ECV was calcu-
lated as (Δ[1/T1myo] / Δ[1/T1blood]) * (1-haematocrit).
Results
ECVT1* was significantly lower than ECVT1 (mean 27.1
±3.4% vs 28.1±3.2%, p<0.0001). ECVT1* showed excellent
correlation with ECVT1 (R= 0.88) (Figure 1). Bland-Altman
analysis revealed no bias or variability (Figure 2). There
was no statistical difference in variance between groups
(F test, p= 0.66). In this group of subjects there was no dif-
ference in ECV between AS and HV groups using either
ECVT1 (28.1±3.2% vs 28.2±3.4%) or ECVT1* (27.3±3.6% vs
26.5±3.0%).
Conclusions
ECV quantification using T1* can measure ECV across
disease and normal populations, but its own normal values
need to be referenced. It has similar variability, and no bias
when compared to ECV using T1blood. ECVT1* is therefore
practically feasible and encourages further work to explore
its theoretical accuracy by histological correlation.
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Figure 1 Excellent correlation between ECV BloodT1 and ECV
BloodT1*
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Figure 2 Little bias and variability between ECV BloodT1 and
BloodT1* using Bland-Altman analysis
Bhuva et al. Journal of Cardiovascular Magnetic
Resonance 2015, 17(Suppl 1):P11
http://www.jcmr-online.com/content/17/S1/P11
Page 2 of 2
